Immunogenicity of hybrid DNA vaccines expressing hepatitis B core particles carrying human and simian immunodeficiency virus epitopes in mice and rhesus macaques

Deborah Heydenburg Fuller, Tim Shipley, Todd M. Allen, James T. Fuller, Mary S. Wu, Helen Horton, Nancy Wilson, Georg Widera, David Watkins

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

An effective HIV vaccine will likely need to induce broad and potent CTL responses. Epitope-based vaccines offer significant potential for inducing multi-specific CTL, but often require conjugation to T helper epitopes or carrier moieties to induce significant responses. We tested hybrid DNA vaccines encoding one or more HIV or SIV CTL epitopes fused to a hepatitis B core antigen (HBcAg) carrier gene as a means to improve the immunogenicity of epitope-based DNA vaccines. Immunization of mice with a HBcAg-HIV epitope DNA vaccine induced CD8+ T cell responses that significantly exceeded levels induced with DNA encoding either the whole HIV antigen or the epitope alone. In rhesus macaques, a multi-epitope hybrid HBcAg-SIV DNA vaccine induced CTL responses to 13 different epitopes, including 3 epitopes that were previously not detected in SIV-infected macaques. These data demonstrate that immunization with hybrid HBcAg-epitope DNA vaccines is an effective strategy to increase the magnitude and breadth of HIV-specific CTL responses.

Original languageEnglish
Pages (from-to)245-255
Number of pages11
JournalVirology
Volume364
Issue number2
DOIs
StatePublished - Aug 1 2007
Externally publishedYes

Fingerprint

Simian Immunodeficiency Virus
DNA Vaccines
Macaca mulatta
Hepatitis B
Epitopes
HIV
Hepatitis B Core Antigens
SAIDS Vaccines
Immunization
HIV Antigens
AIDS Vaccines
Macaca
Vaccines
T-Lymphocytes

Keywords

  • Cytotoxic T lymphocyte response
  • Epitope
  • Hepatitis B core antigen
  • Human immunodeficiency virus
  • Hybrid vaccine
  • nonhuman primate
  • Simian immunodeficiency virus

ASJC Scopus subject areas

  • Virology
  • Infectious Diseases

Cite this

Immunogenicity of hybrid DNA vaccines expressing hepatitis B core particles carrying human and simian immunodeficiency virus epitopes in mice and rhesus macaques. / Fuller, Deborah Heydenburg; Shipley, Tim; Allen, Todd M.; Fuller, James T.; Wu, Mary S.; Horton, Helen; Wilson, Nancy; Widera, Georg; Watkins, David.

In: Virology, Vol. 364, No. 2, 01.08.2007, p. 245-255.

Research output: Contribution to journalArticle

Fuller, Deborah Heydenburg ; Shipley, Tim ; Allen, Todd M. ; Fuller, James T. ; Wu, Mary S. ; Horton, Helen ; Wilson, Nancy ; Widera, Georg ; Watkins, David. / Immunogenicity of hybrid DNA vaccines expressing hepatitis B core particles carrying human and simian immunodeficiency virus epitopes in mice and rhesus macaques. In: Virology. 2007 ; Vol. 364, No. 2. pp. 245-255.
@article{95b9f1aa41744e3e8599c4b7d2a173cf,
title = "Immunogenicity of hybrid DNA vaccines expressing hepatitis B core particles carrying human and simian immunodeficiency virus epitopes in mice and rhesus macaques",
abstract = "An effective HIV vaccine will likely need to induce broad and potent CTL responses. Epitope-based vaccines offer significant potential for inducing multi-specific CTL, but often require conjugation to T helper epitopes or carrier moieties to induce significant responses. We tested hybrid DNA vaccines encoding one or more HIV or SIV CTL epitopes fused to a hepatitis B core antigen (HBcAg) carrier gene as a means to improve the immunogenicity of epitope-based DNA vaccines. Immunization of mice with a HBcAg-HIV epitope DNA vaccine induced CD8+ T cell responses that significantly exceeded levels induced with DNA encoding either the whole HIV antigen or the epitope alone. In rhesus macaques, a multi-epitope hybrid HBcAg-SIV DNA vaccine induced CTL responses to 13 different epitopes, including 3 epitopes that were previously not detected in SIV-infected macaques. These data demonstrate that immunization with hybrid HBcAg-epitope DNA vaccines is an effective strategy to increase the magnitude and breadth of HIV-specific CTL responses.",
keywords = "Cytotoxic T lymphocyte response, Epitope, Hepatitis B core antigen, Human immunodeficiency virus, Hybrid vaccine, nonhuman primate, Simian immunodeficiency virus",
author = "Fuller, {Deborah Heydenburg} and Tim Shipley and Allen, {Todd M.} and Fuller, {James T.} and Wu, {Mary S.} and Helen Horton and Nancy Wilson and Georg Widera and David Watkins",
year = "2007",
month = "8",
day = "1",
doi = "10.1016/j.virol.2007.02.024",
language = "English",
volume = "364",
pages = "245--255",
journal = "Virology",
issn = "0042-6822",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Immunogenicity of hybrid DNA vaccines expressing hepatitis B core particles carrying human and simian immunodeficiency virus epitopes in mice and rhesus macaques

AU - Fuller, Deborah Heydenburg

AU - Shipley, Tim

AU - Allen, Todd M.

AU - Fuller, James T.

AU - Wu, Mary S.

AU - Horton, Helen

AU - Wilson, Nancy

AU - Widera, Georg

AU - Watkins, David

PY - 2007/8/1

Y1 - 2007/8/1

N2 - An effective HIV vaccine will likely need to induce broad and potent CTL responses. Epitope-based vaccines offer significant potential for inducing multi-specific CTL, but often require conjugation to T helper epitopes or carrier moieties to induce significant responses. We tested hybrid DNA vaccines encoding one or more HIV or SIV CTL epitopes fused to a hepatitis B core antigen (HBcAg) carrier gene as a means to improve the immunogenicity of epitope-based DNA vaccines. Immunization of mice with a HBcAg-HIV epitope DNA vaccine induced CD8+ T cell responses that significantly exceeded levels induced with DNA encoding either the whole HIV antigen or the epitope alone. In rhesus macaques, a multi-epitope hybrid HBcAg-SIV DNA vaccine induced CTL responses to 13 different epitopes, including 3 epitopes that were previously not detected in SIV-infected macaques. These data demonstrate that immunization with hybrid HBcAg-epitope DNA vaccines is an effective strategy to increase the magnitude and breadth of HIV-specific CTL responses.

AB - An effective HIV vaccine will likely need to induce broad and potent CTL responses. Epitope-based vaccines offer significant potential for inducing multi-specific CTL, but often require conjugation to T helper epitopes or carrier moieties to induce significant responses. We tested hybrid DNA vaccines encoding one or more HIV or SIV CTL epitopes fused to a hepatitis B core antigen (HBcAg) carrier gene as a means to improve the immunogenicity of epitope-based DNA vaccines. Immunization of mice with a HBcAg-HIV epitope DNA vaccine induced CD8+ T cell responses that significantly exceeded levels induced with DNA encoding either the whole HIV antigen or the epitope alone. In rhesus macaques, a multi-epitope hybrid HBcAg-SIV DNA vaccine induced CTL responses to 13 different epitopes, including 3 epitopes that were previously not detected in SIV-infected macaques. These data demonstrate that immunization with hybrid HBcAg-epitope DNA vaccines is an effective strategy to increase the magnitude and breadth of HIV-specific CTL responses.

KW - Cytotoxic T lymphocyte response

KW - Epitope

KW - Hepatitis B core antigen

KW - Human immunodeficiency virus

KW - Hybrid vaccine

KW - nonhuman primate

KW - Simian immunodeficiency virus

UR - http://www.scopus.com/inward/record.url?scp=34249911224&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249911224&partnerID=8YFLogxK

U2 - 10.1016/j.virol.2007.02.024

DO - 10.1016/j.virol.2007.02.024

M3 - Article

C2 - 17428516

AN - SCOPUS:34249911224

VL - 364

SP - 245

EP - 255

JO - Virology

JF - Virology

SN - 0042-6822

IS - 2

ER -